Latest Supply Chain News

Almonty Industries has commenced commercial production at its flagship Sangdong Mine in South Korea and secured more than US$200 million through Nasdaq IPO and equity offerings to fund expansion projects. Despite rising revenues driven by soaring tungsten prices, the company reported a significant net loss due to non-cash derivative liabilities.

Sarytogan Graphite Limited has received over $2 million from key investor Dias Sarsenov, advancing its share placement strategy and preparing for a pivotal board appointment. Meanwhile, a significant top-up investment from the EBRD awaits shareholder approval.

Diatreme Resources has reported a significant boost in mineral recoveries and production forecasts for its Cyclone Project in Western Australia, driven by advanced metallurgical testwork and flowsheet optimisation.

EV Resources has restructured its Tecomatlán plant acquisition to fast-track antimony production with a low-risk, milestone-based payment plan. Refurbishment is underway, supported by strong metallurgical results and a clear path to near-term output.

Little Green Pharma has terminated its planned sale and leaseback of its Western Australian production facility after failing to reach commercial terms, choosing to retain ownership without impacting operations.

PMET Resources has reported its final 2025 drilling results from the Shaakichiuwaanaan Property, revealing the widest caesium intercept to date at the newly discovered Helios Zone and identifying a new mineralized lens north of the Vega Zone.

Resouro Strategic Metals has appointed Simon Stilwell as Independent Non-Executive Chairman, with Christopher Eager stepping into the CEO role, marking a significant leadership reshuffle as the company advances its rare earths and titanium projects in Brazil.

Caspin Resources has successfully completed a $6 million placement and exercised options, bolstering its position in promising Australian mineral projects focused on tin and gold.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

OMG Group has appointed Food & Dairy Co as the first official distributor of its new matcha brands, opening access to over 2,000 cafes and restaurants in NSW and Queensland. This move marks a key step in OMG’s strategy to expand its health-focused beverage portfolio.

EQ Resources Limited showcased its strategic position as a leading tungsten producer with strong growth ambitions amid a tightening global supply deficit. The company’s dual operations in Australia and Spain underpin its role in securing ethical tungsten supply chains for Western markets.

Aquirian Limited has bolstered its growth trajectory with a $20 million Mt Ida contract and significant advancements in its patented Collar Keeper® system, alongside commissioning its Wubin facility.